DSM receives grant of US
Department of Energy for biotechnology research
Global Life Sciences and Materials Sciences company Royal DSM has received
a grant from the US Department of Energy for a technical biotechnology
research consortium.
The grant for a technical consortium on an innovative biotechnological
approach of bioproducts, will fund an extensive enzyme development program
which will focus on finding applications in cellulose-based biorefineries
for the production of bio-based products, including biofuels. The research
will be carried out by a technical consortium in which Royal DSM N.V.,
headquartered in the Netherlands, will be the lead partner.
The other participants in this proposed project include Abengoa Bioenergy
New Technologies, Los Alamos Laboratory and Sandia National Laboratory.
An important part of the development work will be executed in the US and
the program will run for four years.
The grant fits in with the extensive White Biotech program that DSM is
running as one of its Emerging Business Areas with the aim of becoming
a company fully focused on Life Sciences and Materials Sciences in line
with its strategy Vision 2010. It will enlarge DSM's capabilities as a
leader in biotechnology.
"The focus of this funded program is right at the heart of our White
Biotechnology strategy to create practical solutions for the biorefineries
of the future, using feedstocks that are not in conflict with food and
feed supplies," says Volkert Claassen, DSM's Vice President White
Biotechnology. "We also recognize that it will require solid industry
and institutional partnerships in order to fully realize the potential
of bio-based manufacturing, such as the partners in this particular program."
Commercially feasible
Global developments across all technology platforms in bio-conversion
of cellulosic feedstocks are still at an early stage. In order to create
and utilize commercially feasible solutions, the integration of technologies
across the complete value chain and the manufacturing and entrepreneurial
skills of companies such as of DSM and Abengoa are essential. This collaboration
allows DSM to more rapidly develop and test technology at semi-commercial
and full commercial scale in existing and pilot plants.
DSM's main field of interest in this program is to develop the technical
skills for cellulosic biomass hydrolysis. After completion of this program
DSM will decide upon further research and partners to collaborate within
this field.
Consortium partners
DSM strives to be a leading integrated technology provider for the so-called
second generation processes for biofuel and bio-based chemical production.
DSM brings over a hundred years of experience in enzymes, yeast technology
and industrial fermentation, and is unique in its ability to integrate
these competencies of chemical engineering and biotechnology within a
single entity. Abengoa brings many years of manufacturing, knowledge and
processing capabilities. DSM and its industry, institutional and academic
partners ultimately aim to provide practical solutions across the entire
biorefining technology platform with particular focus on feedstock pretreatment,
enzymatic hydrolysis and advanced fermentation organism technologies.
DSM's products and services end markets include human and animal nutrition
and health, personal care, pharmaceuticals, automotive, coatings and paint,
electrics and electronics, life protection and housing.
Certificate
In Manufacturing Management
Choose 5 or 6 courses for a total of 10 CEU's
The courses listed can be used towards completion of this certificate.
Courses may be applied toward one certificate only. Please note
that some courses may be required.
Get Started Today!
American
Management Online Certification Program Series
Certificate
In Human Resources Management
Courses may be applied toward one certificate only. Please
note that some courses may be required. Choose 5 or 6 courses
for a total of 10 CEU's
Click Here - Sign Up for These Courses Now!
All Rights Reserved. For permission to reproduce any contents of this
web site, please contact our Syndication department: Log onto HELP
